Detalhe da pesquisa
1.
Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis.
Nature
; 616(7958): 755-763, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046083
2.
Clonal Hematopoiesis and Its Impact on Human Health.
Annu Rev Med
; 74: 249-260, 2023 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36450282
3.
Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin.
Blood
; 137(22): 3093-3104, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33598693
4.
Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial.
Blood
; 136(26): 3041-3050, 2020 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33367545
5.
Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia.
Blood
; 135(5): 371-380, 2020 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826241
6.
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group.
Blood
; 134(19): 1608-1618, 2019 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31554635
7.
Genetic alterations in Thai adult patients with acute myeloid leukemia and myelodysplastic syndrome-excess blasts detected by next-generation sequencing technique.
Ann Hematol
; 100(8): 1983-1993, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33839881
8.
Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients.
Leukemia
; 37(11): 2187-2196, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37591941
9.
Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial.
Leukemia
; 36(9): 2218-2227, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35922444
10.
Efficacy and the Adverse Effects of Oral Versus Intravenous Arsenic for Acute Promyelocytic Leukemia: A Meta-Analysis of Randomized-Controlled Studies.
Technol Cancer Res Treat
; 19: 1533033820937008, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32583728
11.
Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1).
Leukemia
; 34(2): 404-415, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31576005
12.
Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication.
Blood Adv
; 4(24): 6342-6352, 2020 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33351131
13.
Correction: Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients.
Leukemia
; 37(11): 2336-2337, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37789148
14.
Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML).
Leukemia
; 34(2): 630-634, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31462736
15.
Intermediate monocytes but not TIE2-expressing monocytes are a sensitive diagnostic indicator for colorectal cancer.
PLoS One
; 7(9): e44450, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22973451